Our Science
Cancer cells like bacteria and viruses, keep multiplying and mutating. Mutations result in therapy resistance. Treating bacterial infections is a successful experience for human beings. Hence, we propose to treat cancers powerfully with broad-spectrum T cell agents in the very beginning as we treat bacterial infection. To avoid side effects, we use therapeutic proteins and cells with a short half-life.
Publications